Emerson Exchange 365

Activity

Embedded Spectral Process Analytic Technology

Jim Cahill

Effective quality assurance processes are essential in pharmaceutical and biopharmaceutical manufacturing processes. Deploying Process Analytical Technologies (PAT) is one way these manufacturers have driven business improvements. Pharma Manufacturing magazine’s Pharma Innovation Awards highlights the technologies and systems driving improvements across manufacturing operations. Their December 2022 article, Pharma Innovation…
- 17 Jan 2023
Embedded Spectral Process Analytic Technology

Jim Cahill

Effective quality assurance processes are essential in pharmaceutical and biopharmaceutical manufacturing processes. Deploying Process Analytical Technologies (PAT) is one way these manufacturers have driven business improvements. Pharma Manufacturing magazine’s Pharma Innovation Awards highlights the technologies and systems driving improvements across manufacturing operations. Their December 2022 article, Pharma Innovation…
- 17 Jan 2023
Improving Digital Maturity is Key to Life Sciences Success

Jim Cahill

In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the life sciences marketplace. In collaboration with other life sciences leaders, Emerson’s Michalle Adkins contributed to a BioPhorum paper outlining a vision…
- 2 Jan 2023
Improving Digital Maturity is Key to Life Sciences Success

Jim Cahill

In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the life sciences marketplace. In collaboration with other life sciences leaders, Emerson’s Michalle Adkins contributed to a BioPhorum paper outlining a vision…
- 2 Jan 2023
Improving Digital Maturity is Key to Life Sciences Success

Jim Cahill

In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the life sciences marketplace. In collaboration with other life sciences leaders, Emerson’s Michalle Adkins contributed to a BioPhorum paper outlining a vision…
- 2 Jan 2023
Real-World Implications of Spectral PAT for Life Sciences

Jim Cahill

There is a growing buzz around spectral process analytical technology (PAT) for the life sciences industry. Spectral PAT sounds really fancy. What is it, and how can it affect my company’s mission to produce treatments and cures that improve the quality of life for our patients? Let’s start with the basics. The ultimate value proposition of every life sciences manufacturer is to produce goods that dramatically improve…
- 20 Dec 2022
Real-World Implications of Spectral PAT for Life Sciences

Jim Cahill

There is a growing buzz around spectral process analytical technology (PAT) for the life sciences industry. Spectral PAT sounds really fancy. What is it, and how can it affect my company’s mission to produce treatments and cures that improve the quality of life for our patients? Let’s start with the basics. The ultimate value proposition of every life sciences manufacturer is to produce goods that dramatically improve…
- 20 Dec 2022
Real-World Implications of Spectral PAT for Life Sciences

Jim Cahill

There is a growing buzz around spectral process analytical technology (PAT) for the life sciences industry. Spectral PAT sounds really fancy. What is it, and how can it affect my company’s mission to produce treatments and cures that improve the quality of life for our patients? Let’s start with the basics. The ultimate value proposition of every life sciences manufacturer is to produce goods that dramatically improve…
- 20 Dec 2022
Leverage Life Sciences Software to Reduce Time to Market

Jim Cahill

The days of maintaining paper records across the life sciences development and production pipeline are gone. Today’s regulatory requirements, not to mention the complexity of new treatments, requires organization that can only be provided electronically. However, while many life sciences teams have moved to electronic records software , many teams are still inadvertently creating data silos—both horizontally across business…
- 29 Nov 2022
Leverage Life Sciences Software to Reduce Time to Market

Jim Cahill

The days of maintaining paper records across the life sciences development and production pipeline are gone. Today’s regulatory requirements, not to mention the complexity of new treatments, requires organization that can only be provided electronically. However, while many life sciences teams have moved to electronic records software , many teams are still inadvertently creating data silos—both horizontally across business…
- 29 Nov 2022
Leverage Life Sciences Software to Reduce Time to Market

Jim Cahill

The days of maintaining paper records across the life sciences development and production pipeline are gone. Today’s regulatory requirements, not to mention the complexity of new treatments, requires organization that can only be provided electronically. However, while many life sciences teams have moved to electronic records software , many teams are still inadvertently creating data silos—both horizontally across business…
- 29 Nov 2022
Module Type Package Unlocks the Flexibility Driving Pharma Innovation

Jim Cahill

There can be little question that Industry 4.0 technologies are reshaping the way life sciences companies operate. In the wake of the rapid development of vaccines during the COVID-19 pandemic , more facilities than ever are being “born digital.” Some of these born-digital facilities are the result of new organizations with entirely digital strategies, and others are biopharmaceutical organizations that have been around…
- 7 Nov 2022
Module Type Package Unlocks the Flexibility Driving Pharma Innovation

Jim Cahill

There can be little question that Industry 4.0 technologies are reshaping the way life sciences companies operate. In the wake of the rapid development of vaccines during the COVID-19 pandemic , more facilities than ever are being “born digital.” Some of these born-digital facilities are the result of new organizations with entirely digital strategies, and others are biopharmaceutical organizations that have been around…
- 7 Nov 2022
Module Type Package Unlocks the Flexibility Driving Pharma Innovation

Jim Cahill

There can be little question that Industry 4.0 technologies are reshaping the way life sciences companies operate. In the wake of the rapid development of vaccines during the COVID-19 pandemic , more facilities than ever are being “born digital.” Some of these born-digital facilities are the result of new organizations with entirely digital strategies, and others are biopharmaceutical organizations that have been around…
- 7 Nov 2022
Let your Personnel Lead you to the Adaptive Plant

Jim Cahill

On Monday at the Emerson Exchange Users’ Conference , Emerson’s Michalle Adkins and AbbVie’s Jeff Ziolkowski moderated a panel with Fujifilm’s Soren Skerris , Takeda’s Dr. Nina Schwalb , Eli Lilly’s James Weber , and Emerson’s Christian Berg . The experts shared the strategies they have employed and the lessons they’ve learned on their journey across the BioPhorum Digital Plant Maturity Model toward creating adaptive…
- 26 Oct 2022
Let your Personnel Lead you to the Adaptive Plant

Jim Cahill

On Monday at the Emerson Exchange Users’ Conference , Emerson’s Michalle Adkins and AbbVie’s Jeff Ziolkowski moderated a panel with Fujifilm’s Soren Skerris , Takeda’s Dr. Nina Schwalb , Eli Lilly’s James Weber , and Emerson’s Christian Berg . The experts shared the strategies they have employed and the lessons they’ve learned on their journey across the BioPhorum Digital Plant Maturity Model toward creating adaptive…
- 26 Oct 2022
Let your Personnel Lead you to the Adaptive Plant

Jim Cahill

On Monday at the Emerson Exchange Users’ Conference , Emerson’s Michalle Adkins and AbbVie’s Jeff Ziolkowski moderated a panel with Fujifilm’s Soren Skerris , Takeda’s Dr. Nina Schwalb , Eli Lilly’s James Weber , and Emerson’s Christian Berg . The experts shared the strategies they have employed and the lessons they’ve learned on their journey across the BioPhorum Digital Plant Maturity Model toward creating adaptive…
- 26 Oct 2022
Reduce Waste & Increase Efficiency in Clean-in-Place Processes

Jim Cahill

While the idea of adding costs to a food and beverage or pharmaceutical industry process like Clean-in-Place/Steam-in-Place (CIP/SIP) has not traditionally been an easy decision, in today’s industrial environment that has changed. With the retirement of experts, the lack of availability of workers, the increase in materials costs and narrowness of margins, the principal way for food and beverage and pharma companies to…
- 21 Oct 2022
Reduce Waste & Increase Efficiency in Clean-in-Place Processes

Jim Cahill

While the idea of adding costs to a food and beverage or pharmaceutical industry process like Clean-in-Place/Steam-in-Place (CIP/SIP) has not traditionally been an easy decision, in today’s industrial environment that has changed. With the retirement of experts, the lack of availability of workers, the increase in materials costs and narrowness of margins, the principal way for food and beverage and pharma companies to…
- 21 Oct 2022
Reduce Waste & Increase Efficiency in Clean-in-Place Processes

Jim Cahill

While the idea of adding costs to a food and beverage or pharmaceutical industry process like Clean-in-Place/Steam-in-Place (CIP/SIP) has not traditionally been an easy decision, in today’s industrial environment that has changed. With the retirement of experts, the lack of availability of workers, the increase in materials costs and narrowness of margins, the principal way for food and beverage and pharma companies to…
- 21 Oct 2022
New Challenges for Gas Analyzer Designers

Jim Cahill

Household waste, industrial emissions, and automobile exhaust are some of the pollutants that can contribute to climate change. They can also make you feel under the weather. In addition, these emissions contribute to the depletion of the Earth’s ozone layer. Due to the threat of these environmental issues, countries around the world have enacted strict legislation aimed at reducing emissions. In the U.S., the EPA…
- 14 Oct 2022
New Challenges for Gas Analyzer Designers

Jim Cahill

Household waste, industrial emissions, and automobile exhaust are some of the pollutants that can contribute to climate change. They can also make you feel under the weather. In addition, these emissions contribute to the depletion of the Earth’s ozone layer. Due to the threat of these environmental issues, countries around the world have enacted strict legislation aimed at reducing emissions. In the U.S., the EPA…
- 14 Oct 2022
New Challenges for Gas Analyzer Designers

Jim Cahill

Household waste, industrial emissions, and automobile exhaust are some of the pollutants that can contribute to climate change. They can also make you feel under the weather. In addition, these emissions contribute to the depletion of the Earth’s ozone layer. Due to the threat of these environmental issues, countries around the world have enacted strict legislation aimed at reducing emissions. In the U.S., the EPA…
- 14 Oct 2022
New Challenges for Gas Analyzer Designers

Jim Cahill

Household waste, industrial emissions, and automobile exhaust are some of the pollutants that can contribute to climate change. They can also make you feel under the weather. In addition, these emissions contribute to the depletion of the Earth’s ozone layer. Due to the threat of these environmental issues, countries around the world have enacted strict legislation aimed at reducing emissions. In the U.S., the EPA…
- 14 Oct 2022
Software Simplifies Technology Transfer

Jim Cahill

The life sciences marketplace is changing faster than nearly any other industry. Gone are the days when companies focus on a single treatment to drive their entire business. Today’s life sciences manufacturers are challenged to bring new treatments to the marketplace as quickly as possible—a trend that was magnified during the COVID-19 pandemic . As a result, innovation is key today. And innovation requires technologies…
- 7 Oct 2022